PRKACG and skin basal cell carcinoma: PRKACG (protein kinase cAMP-activated catalytic subunit gamma) showed the strongest association among KC cases (P = 0.013; Z-score = 2.2) and was also the third strongest association in participants with exclusive BCC development (P = 0.012; Z-score = 1.7).